Cloud Computing is fueling the growth of the Enteral Nutrition Market

 

The global Enteral Nutrition Market is estimated to be valued at US$ 3.1 Bn or Billion in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Enteral nutrition products are nutritional formulas intended for tube feeding through a tube directly into the stomach or small intestine. They are designed to provide nutrition to patients who are unable to meet their nutritional needs through normal diet. These formulas are available in powder, liquid, and semi-solid forms and are customized based on an individual's nutrition requirements.

Market key trends:
One of the key trends in the enteral nutrition market is the growing adoption of cloud-based IT solutions. Various companies in the market are developing digital platforms and mobile applications for remote patient monitoring and management of enteral feeding. For instance, Abbott offers Envisor, a cloud-based platform that allows healthcare providers to digitally manage patients on enteral or parenteral nutrition therapies. Such platforms help maximize efficiency, minimize errors, and improve clinical outcomes through digitalized workflows. They allow remote monitoring of patients, automated data collection, and analytics-based insights for optimized therapy management. This is expected to drive the demand for efficient digital platforms in enteral nutrition over the forecast period.
Segment Analysis

The global enteral nutrition market is segmented into tube feed and oral feed. The tube feed segment dominated the market in 2023 and is expected to remain dominant during the forecast period. Tube feed provides complete and balanced nutrition directly into the stomach or small intestine through a tube for those who cannot consume food orally or have difficulty chewing or swallowing food. It is widely used for patients who are critically ill, mechanically ventilated, or unable to eat normally.

Key Takeaways

The global enteral nutrition market is expected to witness high growth, exhibiting a CAGR of 5.8% over the forecast period, due to increasing incidence of chronic diseases, growing elderly population, and rising malnutrition cases worldwide.

The North American region dominated the global market in 2023 and is expected to maintain its position over the forecast period. This is attributed to the rising prevalence of target diseases, availability of advanced healthcare facilities, and growing awareness regarding enteral feeding. Asia Pacific is anticipated to witness the fastest growth during the forecast period owing to developing healthcare infrastructure and increasing healthcare expenditure in several countries in the region.

Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP. These players are focusing on new product launches, acquisitions, and partnerships to strengthen their market presence. For instance, in 2022, Nestlé Health Science acquired Nutricia Medical Nutrition to expand its enteral feeding business.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more